BioSpace News Archive

Business

Diplomat Partners With CSI Specialty Group to Expand Health System Services

The nation’s largest independent provider of specialty pharmacy services is partnering with CSI Specialty Group to provide specialty pharmacy solutions for hospitals and health systems.

January 7, 2019
·
4 min read
Drug Development

Vifor Pharma receives positive phase-I trial results for oral ferroportin inhibitor

January 7, 2019
·
5 min read
Genetown

Gender Diversity at US Health Care Companies: A Prescription for Progress

Women Make Up More of the US Health Care Workforce Than Men, and They’re More Likely to Be Customers for Health Care. Yet Men Still Run Almost Every Large Company in the Industry. BCG Identified Six Ways to Fix That.

January 7, 2019
·
3 min read
QIAGEN Launches QIAcube Connect – Next-Generation Automation for Sample Processing in Research Labs

Enabling labs to efficiently process increasingly complex samples with over 3,000 proven protocols, advanced digital capabilities and connectivity

January 7, 2019
·
1 min read
Deals

QIAGEN Acquires N-of-One, Expanding Its Clinical Bioinformatics Capabilities in Molecular Oncology Decision Support

Enhancing QIAGEN’s industry-leading position with access to MarkerMine™ database and real-world evidence insights that provide insights for targeted therapy options

January 7, 2019
·
1 min read
Business

ViewRay Announces Preliminary Fourth Quarter and Fiscal Year 2018 Results

ViewRay, Inc. today announced preliminary results for the fourth quarter and full fiscal year ended December 31, 2018. The preliminary results have not been audited and are subject to change.

January 7, 2019
·
3 min read
Business

TransEnterix Provides Corporate Update 2018

Achieved preliminary unaudited revenue of approximately $7.4 million for the fourth quarter of 2018

January 7, 2019
·
6 min read
Business

NovaBay Pharmaceuticals Announces Preliminary 2018 Net Sales and Introduces 2019 Net Sales Guidance

NovaBay® Pharmaceuticals, Inc. announces 2018 net sales are expected to be $12.6 million to $12.7 million.

January 7, 2019
·
5 min read
Policy

Neptune Receives License to Process Cannabis from Health Canada

Neptune Wellness Solutions Inc. is pleased to announce today that it has received its license to process cannabis from Health Canada.

January 7, 2019
·
6 min read
Drug Development

Syndax Highlights 2019 Clinical and Corporate Outlook

Data from ENCORE I/O combination program in melanoma and ovarian cancer expected in 1Q19, TNBC in 2Q19

January 7, 2019
·
7 min read